Multi-layered Network Analysis of Osteoking in the Treatment of Osteoporosis: Unraveling Mechanisms from Gene Expression to Molecular Docking
He CheniD, Binwu YingiD, Xianjie Xie, Boyun Huang, Pengcheng Lin
Abstract
This study aimed to elucidate the therapeutic mechanisms of Osteoking in the treatment of osteoporosis through a comprehensive analysis of potential targets, active ingredients, and associated pathways. MethodThe study employed an integrated approach to understand the molecular mechanisms underlying Osteokings treatment of osteoporosis. The construction of the protein-protein interaction network involved analyzing data from GENEMANIA and STRING databases. KEGG enrichment analysis was performed to identify enriched pathways, focusing on the cAMP signaling and PI3K-AKT signaling pathways. Active ingredients, disease targets, and osteoporosis-related pathways were integrated into a comprehensive network diagram using Cytoscape. ResultThe Gene Expression Omnibus (GEO) database was employed to identify osteoporosis-related gene targets, revealing 3,578 downregulated and 1,204 upregulated genes. Simultaneously, Osteokings active ingredients and potential targets were investigated using the Traditional Chinese Medicine Integrated Database (ETCM). A protein-protein interaction network and KEGG pathway enrichment analysis were constructed, highlighting potential targets for Osteokings therapeutic effects on osteoporosis. The study also conducted molecular docking analysis, revealing the strong binding capacities of Kaempferol with key disease targets. The results suggest that Osteoking, particularly its active component Kaempferol, holds promise as a potential intervention for osteoporosis, providing insights for further exploration and development of osteoporosis treatments ConclusionsIn conclusion, despite some limitations, this study provides valuable information for the treatment of osteoporosis. Future research should make further progress by continually expanding data sources, conducting in-depth experimental validations, and broadening the scope of targets to better understand and address this common skeletal disorder. FundingThis work was supported by the Scientific Foundation of Fuzhou Municipal Health Commission (2021-S-wp3).
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Potential Mechanisms Underlying Kaempferol-Promoted Osteoblast Proliferation and Osteogenic Differentiation: A Network Pharmacology and Experimental Validation Study
Huixi Wang, Guohan Xiang, … Donghui Guan·Letters in Drug Design & DiscoveryPeer-reviewed·Apr 1, 2026
- Multi-omics analyses of drug repurposing reveal Acebutolol and Amiloride for osteoporosis treatment
Danyang Liu, Jonathan Greenbaum, … Hong‐Wen Deng·bioRxiv·May 3, 2022
- Modeling osteoporosis to design and optimize pharmacologic therapies comprising multiple drug types
D. J. Jörg, D. H. Fuertinger, … P. Kotanko·bioRxiv·Dec 17, 2021
- Comprehensive bioinformatic analysis reveals novel potential diagnostic biomarkers associated with monocytes in osteoporosis
Xianyun Qin, Bo Wen, … Zhiyou Mao·bioRxiv·Mar 24, 2026
- Network pharmacology, bioinformatics, molecular docking and experimental verification of the mechanism of HXZTS treatment on osteoarthritis synovium
Li‐Qun Chen, Hongxiu Wang, … Wenhui He·bioRxiv·Sep 25, 2025
- G protein-coupled receptor 35 (GPR35) stimulation reduces osteoclast activity in primary human bone cells
Maria L. Price, Rachael A. Wyatt, … Caroline M. Gorvin·bioRxiv·Apr 21, 2025